Drug Shortage Report for CYMBALTA
Report ID | 177305 |
Drug Identification Number | 02301490 |
Brand name | CYMBALTA |
Common or Proper name | Duloxetine hydrochloride delayed release capsules |
Company Name | ELI LILLY CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DULOXETINE |
Strength(s) | 60MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | Carton containing 28 capsules in blister packaging |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-05 |
Estimated end date | 2022-12-22 |
Actual end date | 2022-12-22 |
Shortage status | Resolved |
Updated date | 2022-12-23 |
Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-12-23 | English | Compare |
v5 | 2022-12-22 | French | Compare |
v4 | 2022-12-22 | English | Compare |
v3 | 2022-12-22 | English | Compare |
v2 | 2022-12-07 | French | Compare |
v1 | 2022-12-07 | English | Compare |
Showing 1 to 6 of 6